CE2 - COST-EFFECTIVENESS OF A NEW SINGLE INHALER TRIPLE THERAPY VERSUS A DUAL INHALED CORTICOSTEROID PLUS LONG-ACTING BETA AGONIST IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SPAIN
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.014
https://www.valueinhealthjournal.com/article/S1098-3015(18)33314-X/fulltext
Section Title :
Section Order :
1148
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33314-X&doi=10.1016/j.jval.2018.09.014